China Money Network
Login
Join

Ally Bridge Backs Go-Private Deal of Chinese Pharmaceutical Firm Luoxin

  • March 15, 2017 — 03:15 CST

This Data Is Locked!

This area is available only to Subscribers.

Ally Bridge Group, a Hong Kong-based healthcare-focused private equity firm, has proposed a HK$2.34 billion (US$301 million) privatization deal to take Hong Kong-listed Shangdong Luoxin... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: